Health Catalyst Reports Third Quarter 2021 Results

Go back to Health Catalyst Reports Third Quarter 2021 Results

Health Catalyst (HCAT) Tops Q3 EPS by 4c

November 9, 2021 4:35 PM EST

Health Catalyst (NASDAQ: HCAT) reported Q3 EPS of ($0.18), $0.04 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $61.74 million versus the consensus estimate of $60.81 million.

GUIDANCE:

Health Catalyst sees FY2021 revenue of $238.6-241.6 million, versus the consensus... More